Abstract:Currently, one of the challenge of the steroid industry is to achieve the production of C22 intermediates, such as 22‐hydroxy‐23,24‐bisnorchol‐4‐ene‐3‐one (4‐HBC), from phytosterols by metabolic engineering avoiding the presence of by‐products contamination. C22 steroids are used for the synthesis of progesterone in the pharma industry. This work studies the role of an aldehyde dehydrogenase coded by the MSMEG_6563 gene of Mycolicibacterium smegmatis, named msRed, in 4‐HBC production. msRed performs the reduction of 3‐oxo‐4‐pregnene‐20‐carboxyl aldehyde (3‐OPA) to 4‐HBC. msOpccR reductase encoded by MSMEG_1623 was also studied confirming that it also reduces 3‐OPA into 4‐HBC, but less efficiently than msRed. We have engineered M. smegmatis to increase metabolic flux of sterols towards the production of 4‐HBC (red arrows and symbols). The resulting strain showed an improved performance on 4‐HBC production demonstrating a great potential for its industrial application. The 22‐hydroxy‐23,24‐bisnorchol‐4‐ene‐3‐one (4‐HBC) is a C22 steroid synthon of pharmaceutical interest that can be produced as a lateral end‐product of the catabolism of natural sterols (e.g., cholesterol or phytosterols). This work studies the role of an aldehyde dehydrogenase coded by the MSMEG_6563 gene of Mycolicibacterium smegmatis, named msRed, in 4‐HBC production. This gene is located contiguously to the MSMEG_6561 encoding the aldolase msSal which catalyses the retroaldol elimination of acetyl‐CoA of the metabolite intermediate 22‐hydroxy‐3‐oxo‐cholest‐4‐ene‐24‐carboxyl‐CoA to deliver 3‐oxo‐4‐pregnene‐20‐carboxyl aldehyde (3‐OPA). We have demonstrated that msRed reduces 3‐OPA to 4‐HBC. Moreover, the role of msOpccR reductase encoded by MSMEG_1623 was also explored confirming that it also performs the reduction of 3‐OPA into 4‐HBC, but less efficiently than msRed. To obtain a M. smegmatis 4‐HBC producer strain we deleted MSMEG_5903 (hsd4A) gene in strain MS6039‐5941 (ΔkshB1, ΔkstD1) that produces 4‐androstene‐3,17‐dione (AD) from natural sterols (cholesterol or phytosterols). The triple MS6039‐5941‐5903 mutant was able to produce 9 g/L of 4‐HBC from 14 g/L of phytosterols in 2 L bioreactor, showing a productivity of 0.140 g/L h−1. To improve the metabolic flux of sterols towards the production of 4‐HBC we have cloned and overexpressed the msSal and msRed enzymes in the MS6039‐5941‐5903 mutant rendering a production titter of 12.7 g/L with a productivity of 0.185 g/L h−1, and demonstrating that the new recombinant strain has a great potential for its industrial application.

High‐efficiency bioconversion of phytosterol to bisnoralcohol by metabolically engineered Mycobacterium neoaurum in a micro‐emulsion system

Improving the Production of 22-Hydroxy-23,24-bisnorchol-4-ene-3-one from Sterols in Mycobacterium Neoaurum by Increasing Cell Permeability and Modifying Multiple Genes.

Efficient conversion of phytosterols into 4-androstene-3,17-dione and its C1,2-dehydrogenized and 9α-hydroxylated derivatives by engineered Mycobacteria

Production of 9,21-dihydroxy-20-methyl-pregna-4-en-3-one from phytosterols in Mycobacterium neoaurum by modifying multiple genes and improving the intracellular environment

Unravelling and engineering an operon involved in the side-chain degradation of sterols in Mycolicibacterium neoaurum for the production of steroid synthons

Enhancing the bioconversion of steroidal intermediates from phytosterols by the deficiency of kasB in the cell wall synthesis of Mycobacterium neoaurum

Enhancing the Bioconversion of Phytosterols to Steroidal Intermediates by the Deficiency of Kasb in the Cell Wall Synthesis of Mycobacterium Neoaurum

Unraveling and engineering the production of 23,24-bisnorcholenic steroids in sterol metabolism

Improving the production of 22‐hydroxy‐23,24‐bisnorchol‐4‐ene‐3‐one in Mycolicibacterium smegmatis

Engineered 3-Ketosteroid 9Α-Hydroxylases in Mycobacterium Neoaurum: an Efficient Platform for Production of Steroid Drugs

Characterization and engineering of 3-ketosteroid-△1-dehydrogenase and 3-ketosteroid-9α-hydroxylase in Mycobacterium neoaurum ATCC 25795 to produce 9α-hydroxy-4-androstene-3,17-dione through the catabolism of sterols.

Improving the biotransformation of phytosterols to 9α-hydroxy-4-androstene-3,17-dione by deleting embC associated with the assembly of cell envelope in Mycobacterium neoaurum

Efficient Production of 9,22-Dihydroxy-23,24-bisnorchol-4-ene-3-one from Phytosterols by Modifying Multiple Genes in Mycobacterium fortuitum

Construction of a Cell Factory for the Targeted and Efficient Production of Phytosterol to Boldenone in Mycobacterium neoaurum

Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways

Rerouting phytosterol degradation pathway for directed androst-1,4-diene-3,17-dione microbial bioconversion

Enhancing Production and Purity of 9-OH-AD from Phytosterols by Balancing Metabolic Flux of the Side-Chain Degradation and 9-Position Hydroxylation in Mycobacterium Neoaurum

Two-Step Bioprocess for Reducing Nucleus Degradation in Phytosterol Bioconversion by Mycobacterium neoaurum NwIB-R10 hsd4A

Driving the Conversion of Phytosterol to 9Α-Hydroxy-4-androstene-3,17-dione in Mycolicibacterium Neoaurum by Engineering the Supply and Regeneration of Flavin Adenine Dinucleotide

A Combined Strategy to Enhance Phytosterols Biotransformation to 22-Hydroxy-23,24-bisnorchol-4-ene-3-one by Mycobacterium Neoaurum

One-pot biosynthesis of 7β-hydroxyandrost-4-ene-3,17-dione from phytosterols by cofactor regeneration system in engineered mycolicibacterium neoaurum